Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs Queen RX

By GLP-1 ScorecardUpdated

NewSelf
Site position #39

Higher grade

Queen RX
Site position #216

Lower grade

Score comparison

NewSelf has the higher recorded score — 79.8/100 to 66.3/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNewSelf +16
93
77
Dose & formulationNewSelf +23
80
57
Clinical oversightQueen RX +14
55
69
Labs & monitoringNewSelf +29
82
53
FulfillmentNewSelf +12
87
75
Contract termsNewSelf +24
85
61
NewSelf · top barQueen RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNewSelfQueen RX
WeighScore79.8/10066.3/100
GradeC+C
Site position#39#216
Semaglutide$100/mo$100/mo (quarterly plan, compounded)
Tirzepatide$144/moNot disclosed
CoverageAll 50 states45 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
NewSelf

Site position #39 · C+

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

What to consider

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history
Queen RX

Site position #216 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

What to consider

  • LegitScript or PCAB accreditation has not been independently verified
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard